A new paper "Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies", led by Renaud La Joie, was just published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
Dr Kostas Chiotis' review on "The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies" is now published in the Journal Of Nuclear Medicine. Co-authors include Renaud La Joie and Gil Rabinovici (senior author), and Yingbing Wang, a UCSF radiologist and close collaborator to…
For the second year in a row, both Gil and Renaud were listed on the Clarivate list of most influential scientists, based on the citations of their publications in the past year. 48 other scientists from UCSF are part of this list, including several colaborators from the Edward and Pearl Fein…
Only a few months after she left the lab to start her PhD at UPenn, Xiuxiu got her first first author paper out! This is now available on pubmed and the Journal Of Nuclear Medicine wesbite.
On Friday June 13th, Marlene Lin succesfully defended her Master's thesis entitled "Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease".
Gil was a guest on the last dementia matters episode. He talked about the role of tau-PET in Alzheimer's research, clinical trial development, and clinical care.
Dementia Matters is a podcast about Alzheimer's disease and dementia, hosted by Dr Nathaniel Chin, a neurologist at the Wisconsin…
Three of our Clinical Research Coordinators, Salma Rocha, Alinda Amuiri, and Ranjani Shankar are attending the 2025 meeting of the International Neuropsychological Society in New Orleans. Each of them is presenting a poster on the research they have been conducting at the UCSF Memory and Aging…
